Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
Conditions: Symptomatic Neurogenic Orthostatic Hypertension; nOH Interventions: Drug: Ampreloxetine ; Drug: Ampreloxetine ; Drug: Ampreloxetine Placebo; Drug: Moxifloxacin; Drug: Moxifloxacin Placebo Sponsor: Theravance Biopharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials